1887
8 - The 3rd Mustansiriyah International Dental Conference
  • ISSN: 1999-7086
  • EISSN: 1999-7094

Abstract

Recently, the importance of salivary proteins as periodontal disease biomarkers creates “high-impact diagnostics” that significantly influence clinical judgment, patient outcomes, and healthcare costs. The study aimed to evaluate the diagnostic accuracy of salivary biomarkers Matrix metalloproteinase-9 (MMP-9) as well as interleukin-6 (IL-6) in distinguishing between various stages of periodontitis and healthy individuals.

A case-control study of 120 volunteers was classified into four groups based on periodontal health: healthy controls, stage I, II, and III periodontitis. Salivary samples were collected, and an enzyme-linked immune sorbent assay was employed to measure IL-6 and MMP-9 levels. The diagnostic precision of both biomarkers was evaluated using the area under curve (AUC) and receiver operating characteristic (ROC).

IL-6 demonstrated strong diagnostic ability; its AUC values ranged from 0.888 to 1 across comparisons. Precisely, in differentiating control from stage III periodontitis, IL-6 showed a perfect diagnostic efficacy at a cut-off of 5.75. Conversely, MMP-9 exhibited diverse AUC values according to the stage of disease with a cut-off of 1.715, when comparing the control to stage III.

Salivary IL-6 consistently demonstrates robust diagnostic accuracy in distinguishing periodontitis stages, suggesting its potential as a valuable tool for non-invasive periodontal assessments. MMP-9 also presents diagnostic promise, and its application is more stage-specific.

Loading

Article metrics loading...

/content/journals/10.5339/jemtac.2024.midc.1
2024-12-24
2025-01-22
Loading full text...

Full text loading...

/deliver/fulltext/jemtac/2024/8/jemtac.2024.midc.1.html?itemId=/content/journals/10.5339/jemtac.2024.midc.1&mimeType=html&fmt=ahah

References

  1. Mohammed MA, Abbas RF, Akram HM. Salivary IL-17 and IL-10 as Potential Diagnostic Biomarkers of Different Stages of Periodontitis in Smoker and Nonsmoker Patients. Eur J Dent. 2024Feb; 18:(1):253–64. https://doi.org/10.1055/s-0043-1768154
    [Google Scholar]
  2. Mahmood AA, Abbas RF. Assessment of NLRP3 Gene Polymorphisms with Periodontitis as Compared with Healthy Periodontium in Iraqi Arabs Patients. Eur J Dent. 2023Oct; 17:(4):1338–48. https://doi.org/10.1055/s-0043-1761185
    [Google Scholar]
  3. Kzar WA, Abbas RF, Hussein HM. The Antimicrobial Peptide LL-37 as a Predictor Biomarker for Periodontitis with the Presence and Absence of Smoking: A Case-Control Study. Biomed Res Int. 2023; 2023:5581267. https://doi.org/10.1155/2023/5581267
    [Google Scholar]
  4. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ; CDC Periodontal Disease Surveillance workgroup: James Beck (University of North Carolina, Chapel Hill, USA), Gordon Douglass (Past President, American Academy of Periodontology), Roy Page (University of Washinton). Prevalence of Periodontitis in Adults in the United States: 2009 and 2010. J Dent Res. 2012; 91:(10):914–20. https://doi.org/10.1177/0022034512457373
    [Google Scholar]
  5. Holtfreter B, Kocher T, Hoffmann T, Desvarieux M, Micheelis W. Prevalence of Periodontal Disease and Treatment Demands Based on a German Dental Survey (DMS IV). J Clin Periodontol. 2010; 37:(3):211–9. https://doi.org/10.1111/j.1600-051X.2009.01517.x
    [Google Scholar]
  6. Armitage GC. The Complete Periodontal Examination. Periodontology 2000. 2004; 34:22–33. https://doi.org/10.1046/j.0906-6713.2002.003422.x
    [Google Scholar]
  7. Mahmood AA, Abbas RF, Hussein HM. Novel Association Between Single-Nucleotide Polymorphisms of IKKβ at rs17875746 and rs12676482 and Periodontitis. Dent Med Probl. 2023; 60:(4):627–34. https://doi.org/10.17219/dmp/170879
    [Google Scholar]
  8. Hussein HM, Mahmood AA, Alberaqdar FA. The Prevalence and Relationship of Root Caries Depth and Gingival Recession Among Different Iraqi Groups. Mustansiria Dent J. 2015; 12:(1):144–55. https://doi.org/10.32828/mdj.v12i1.840
    [Google Scholar]
  9. Gursoy UK, Könönen E, Pussinen PJ, Tervahartiala T, Hyvärinen K, Suominen AL, et al. Use of Host- and Bacteria-Derived Salivary Markers in Detection of Periodontitis: A Cumulative Approach. Dis Mark. 2011; 30:(6):299–305. https://doi.org/10.3233/DMA-2011-0788
    [Google Scholar]
  10. Taba M, Jr., Kinney J, Kim AS, Giannobile WV. Diagnostic Biomarkers for Oral and Periodontal Diseases. Dent Clin North Am. 2005; 49:(3):551–71, vi. https://doi.org/10.1016/j.cden.2005.03.009
    [Google Scholar]
  11. Gabay C. Interleukin-6 and Chronic Inflammation. Arthritis Res Ther. 2006; 8:(Suppl. 2):S3. https://doi.org/10.1186/ar1917
    [Google Scholar]
  12. Li W, Zhu Y, Singh P, Ajmera DP, Song J, Ji P. Association of Common Variants in MMPs with Periodontitis Risk. Dis Mark. 2016: 2016:1545974. https://doi.org/10.1155/2016/1545974
    [Google Scholar]
  13. Franco C, Patricia HR, Timo S, Claudia B, Marcela H. Matrix Metalloproteinases as Regulators of Periodontal Inflammation. Int J Mol Sci. 2017; 18:(2):440. https://doi:10.3390/ijms18020440
    [Google Scholar]
  14. Gursoy UK, Könönen E, Huumonen S, Tervahartiala T, Pussinen PJ, Suominen AL, et al. Salivary Type I Collagen Degradation End-Products and Related Matrix Metalloproteinases in Periodontitis. J Clin Periodontol. 2013; 40:(1):18–25. https://doi.org/10.1111/jcpe.12020
    [Google Scholar]
  15. Söder PO, Meurman JH, Jogestrand T, Nowak J, Söder B. Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Blood as Markers for Early Atherosclerosis in Subjects with Chronic Periodontitis. J Periodontal Res. 2009; 44:(4):452–8. https://doi.org/10.1111/j.1600-0765.2008.01145.x
    [Google Scholar]
  16. Sharma SK, Mudgal SK, Thakur K, Gaur R. How to Calculate Sample Size for Observational and Experimental Nursing Research Studies. Natl J Physiol Pharm Pharmacol. 2020; 10:(1):1-8. https://doi.org/10.5455/njppp.2020.10.0930717102019
    [Google Scholar]
  17. Tonetti MS, Greenwell H, Kornman KS. Staging and Grading of Periodontitis: Framework and Proposal of a New Classification and Case Definition. J Clin Periodontol. 2018; 45:(20):S149–S61.
    [Google Scholar]
  18. David Bowers. Medical Statistics from Scratch: An Introduction for Health Professionals. Wiley-Intersciencefourth ed. 2019.
    [Google Scholar]
  19. Jung S, Gavriiloglou M, Séverac F, Haumesser L, Sayeh A, Chatelus E, et al. Influence of Systemic Sclerosis on Periodontal Health: A Case-Control Study. J Clin Periodontol. 2023; 50:(10):1348–59. https://doi.org/10.1111/jcpe.13846
    [Google Scholar]
  20. Kazem NM, Abdulkareem AA, Milward MR. Salivary E-Cadherin as a Biomarker for Diagnosis and Predicting Grade of Periodontitis. J Period Res. 2023; 58:(4):715–22. https://doi: 10.1111/jre.13125
    [Google Scholar]
  21. Kc S, Wang XZ, Gallagher JE. Diagnostic Sensitivity and Specificity of Host-Derived Salivary Biomarkers in Periodontal Disease Amongst Adults: Systematic Review. J Clin Periodontol. 2020; 47:(3):289–308. https://doi.org/10.1111/jcpe.13218
    [Google Scholar]
  22. Kim JY, Kim HN. Changes in Inflammatory Cytokines in Saliva After Non-Surgical Periodontal Therapy: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2021; 18:(1):194. https://doi.org/10.3390/ijerph18010194
    [Google Scholar]
  23. Reddahi S, Bouziane A, Rida S, Tligui H, Ennibi O. Salivary Biomarkers in Periodontitis Patients: A Pilot Study. Int J Dent. 2022; 2022:3664516. https://doi.org/10.1155/2022/3664516
    [Google Scholar]
  24. Tanvir I, Ehsanulhaq M, Salahuddin H, Tligui H, Ennibi O. Salivary Biomarkers in the Diagnosis of Periodontitis. Pak J Med Health Sci. 2022; 16:(08):942.
    [Google Scholar]
  25. Zhang F, Liu E, Radaic A, Yu X, Yang S, Yu C, et al. Diagnostic Potential and Future Directions of Matrix Metalloproteinases as Biomarkers in Gingival Crevicular Fluid of Oral and Systemic Diseases. Int J Biol Macromol. 2021; 188:180–96. https://doi.org/10.1016/j.ijbiomac.2021.07.165
    [Google Scholar]
  26. Al-Alawi Z, Abdul Aziz Ahmed M. Anti-oxidant Efficacy of Ginger Containing Dentifrice in the Control of Biofilm Induced Gingivitis (Randomized Parallel Clinical Trial). Mustansiria Dent J. 2023; 19:(2):241–50. https://doi.org/10.32828/mdj.v19i2.936
    [Google Scholar]
/content/journals/10.5339/jemtac.2024.midc.1
Loading
/content/journals/10.5339/jemtac.2024.midc.1
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error